IL147037A0 - Peptide acceptor ligation methods - Google Patents

Peptide acceptor ligation methods

Info

Publication number
IL147037A0
IL147037A0 IL14703700A IL14703700A IL147037A0 IL 147037 A0 IL147037 A0 IL 147037A0 IL 14703700 A IL14703700 A IL 14703700A IL 14703700 A IL14703700 A IL 14703700A IL 147037 A0 IL147037 A0 IL 147037A0
Authority
IL
Israel
Prior art keywords
peptide acceptor
ligation methods
acceptor ligation
methods
peptide
Prior art date
Application number
IL14703700A
Other languages
English (en)
Original Assignee
Phylos Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phylos Inc filed Critical Phylos Inc
Publication of IL147037A0 publication Critical patent/IL147037A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
    • C07K17/02—Peptides being immobilised on, or in, an organic carrier
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • C12N15/1006—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1062—Isolating an individual clone by screening libraries mRNA-Display, e.g. polypeptide and encoding template are connected covalently
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1075—Isolating an individual clone by screening libraries by coupling phenotype to genotype, not provided for in other groups of this subclass
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IL14703700A 1999-07-27 2000-07-19 Peptide acceptor ligation methods IL147037A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14583499P 1999-07-27 1999-07-27
PCT/US2000/019653 WO2001007657A1 (fr) 1999-07-27 2000-07-19 Methodes de ligature d'un accepteur de peptide

Publications (1)

Publication Number Publication Date
IL147037A0 true IL147037A0 (en) 2002-08-14

Family

ID=22514769

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14703700A IL147037A0 (en) 1999-07-27 2000-07-19 Peptide acceptor ligation methods

Country Status (16)

Country Link
US (3) US6429300B1 (fr)
EP (2) EP1196637B1 (fr)
JP (2) JP4766808B2 (fr)
KR (1) KR20020033743A (fr)
AT (2) ATE360706T1 (fr)
AU (2) AU781783B2 (fr)
CA (2) CA2693274C (fr)
CY (1) CY1113185T1 (fr)
DE (1) DE60034566T2 (fr)
DK (2) DK1196637T3 (fr)
ES (2) ES2284508T3 (fr)
HK (2) HK1045334A1 (fr)
IL (1) IL147037A0 (fr)
NO (1) NO20020348D0 (fr)
PT (2) PT1870417E (fr)
WO (1) WO2001007657A1 (fr)

Families Citing this family (102)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1870417E (pt) * 1999-07-27 2012-06-01 Bristol Myers Squibb Co Métodos de ligação de aceitador peptídico
JP4731781B2 (ja) 2000-01-11 2011-07-27 ナノゲン・レコグノミクス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 基体表面に結合させるための複数の結合部分を有する生体分子
AU2001262152A1 (en) * 2000-03-31 2001-10-08 Memorec Stoffel Gmbh Method for extracting nucleic acids
WO2003044194A1 (fr) * 2001-11-16 2003-05-30 Proteonova, Inc. Selection et evolution d'acides nucleiques et de polypeptides
US6962781B1 (en) 2000-05-19 2005-11-08 Proteonova, Inc. In vitro evolution of nucleic acids and encoded polypeptide
US7410761B2 (en) * 2000-05-19 2008-08-12 Proteonova, Inc. System for rapid identification and selection of nucleic acids and polypeptides, and method thereof
US20040229271A1 (en) * 2000-05-19 2004-11-18 Williams Richard B. Compositions and methods for the identification and selection of nucleic acids and polypeptides
JP4880182B2 (ja) * 2000-08-11 2012-02-22 ナノジェン・レコグノミクス・ゲーエムベーハー ヒドラジド結合部分を有する巨大分子およびそれらの製造用試剤
US7129229B2 (en) 2000-08-11 2006-10-31 Nanogen Recognomics Gmbh Hydrazide building blocks and hydrazide modified biomolecules
JP4963142B2 (ja) * 2000-12-14 2012-06-27 学校法人慶應義塾 遺伝子型と表現型の対応付け分子とその構成要素、および対応付け分子の製造方法と利用方法
WO2002102820A1 (fr) 2001-06-20 2002-12-27 Nuevolution A/S Derives nucleosidiques pour elaboration de bibliotheque combinatoire
US20060234231A1 (en) * 2001-06-20 2006-10-19 Nuevolution A/S Microarrays displaying encoded molecules
US6893822B2 (en) 2001-07-19 2005-05-17 Nanogen Recognomics Gmbh Enzymatic modification of a nucleic acid-synthetic binding unit conjugate
WO2003012146A1 (fr) * 2001-07-31 2003-02-13 Phylos, Inc. Assemblage modulaire de multimeres de fusion acides nucleiques-proteines
DE10147074A1 (de) * 2001-09-25 2003-05-08 Beru Ag Verfahren zum Betreiben einer aus mehreren Heizelementen bestehenden mehrstufigen elektrischen Heizung
AU2002365404A1 (en) 2001-11-27 2003-06-10 Compound Therapeutics, Inc. Solid-phase immobilization of proteins and peptides
DE20200926U1 (de) * 2002-01-23 2002-04-18 Hegenscheidt Mfd Gmbh & Co Kg Festwalzgerät einer Festwalzmaschine für Kurbelwellen
AU2003214031A1 (en) * 2002-03-15 2003-09-29 Nuevolution A/S An improved method for synthesising templated molecules
US20050221318A1 (en) * 2002-03-15 2005-10-06 Gouliaev Alex H Building block forming a c-c bond upon reaction
EP1487850A2 (fr) * 2002-03-15 2004-12-22 Nuevolution A/S Bloc de construction formant une liaison atomique c-c ou c hetero apres reaction
EP1487851A2 (fr) * 2002-03-15 2004-12-22 Nuevolution A/S Element constitutif capable de transferer une entite fonctionnelle vers un nucleophile
WO2004013070A2 (fr) * 2002-08-01 2004-02-12 Nuevolution A/S Synthese en plusieurs etapes de molecules synthetisees
WO2004015075A2 (fr) * 2002-08-08 2004-02-19 Dharmacon, Inc. Arn interferant courts possedant une structure en epingle a cheveux contenant une boucle non nucleotidique
CN102838654B (zh) 2002-10-30 2016-05-18 纽韦卢森公司 合成双功能复合物的方法
AU2003291964A1 (en) * 2002-12-19 2004-07-14 Nuevolution A/S Quasirandom structure and function guided synthesis methods
US20070026397A1 (en) * 2003-02-21 2007-02-01 Nuevolution A/S Method for producing second-generation library
US20060269920A1 (en) * 2003-02-21 2006-11-30 Nuevolution A/S Method for obtaining structural information about an encoded molecule
EP1608748B1 (fr) * 2003-03-20 2009-03-04 Nuevolution A/S Codage par ligature de petites molecules
WO2004110964A2 (fr) * 2003-06-16 2004-12-23 Nuevolution A/S Molecules codees par traduction genetique (emt)
US20050095627A1 (en) * 2003-09-03 2005-05-05 The Salk Institute For Biological Studies Multiple antigen detection assays and reagents
DK1670939T3 (da) 2003-09-18 2010-03-01 Nuevolution As Fremgangsmåde til opnåelse af strukturel information om et kodet molekyle og fremgangsmåde til udvælgelse af forbindelser
EP1692313A2 (fr) * 2003-11-20 2006-08-23 Sanofi Pasteur Inc. Procedes de purification de l'anatoxine coquelucheuse et peptides utiles pour ceux-ci
BRPI0417302A (pt) 2003-12-05 2007-03-06 Compound Therapeutics Inc inibidores de receptores de fator de crescimento endotelial vascular do tipo 2
EP1692155A4 (fr) * 2003-12-12 2008-08-06 Proteonova Inc Systemes et procedes pour la selection d'acide nucleique et de polypeptide
EP1723255B1 (fr) * 2004-02-17 2010-12-29 Nuevolution A/S Methode d'elimination visant a un enrichissement par hybridation de mesappariements
EP1730277B1 (fr) * 2004-03-22 2009-10-28 Nuevolution A/S Codage par ligature utilisant des oligonucleotides motifs structuraux
CA2467321A1 (fr) * 2004-05-14 2005-11-14 Paul J. Santerre Agents de couplage polymeres et polymeres ayant une activite pharmaceutique produits a partir de ceux-ci
US8445413B2 (en) 2004-10-15 2013-05-21 National Institute Of Advanced Industrial Science And Technology Linker for constructing mRNA-puromycin-protein conjugate
US10206998B2 (en) 2005-01-12 2019-02-19 Proteonova, Inc. Modular targeted therapeutic agents and methods of making same
WO2006076417A1 (fr) 2005-01-12 2006-07-20 Proteonova, Inc. Procédé de fabrication d'agents thérapeutiques ciblés
KR20080079643A (ko) 2005-11-16 2008-09-01 암브룩스, 인코포레이티드 비-천연 아미노산을 포함하는 방법 및 조성물
SI3305900T1 (sl) 2005-12-01 2022-02-28 Nuevolution A/S Postopki encimskega kodiranja za učinkovito sintezo velikih knjižnic
US7749957B2 (en) 2006-04-06 2010-07-06 E.I. Du Pont De Nemours And Company Clay-binding peptides and methods of use
BRPI0719597A2 (pt) 2006-11-22 2013-12-17 Adnexus A Bristol Myers Squibb R & D Company Produtos terapêuticos objetivados baseados em proteínas manipuladas para receptores de quinases de tirosina, incluindo igf-ir
CA2677804C (fr) 2007-02-12 2017-03-14 Proteonova, Inc. Generation d'une bibliotheque de polypeptides aleatoires solubles lies a l'arnm
US7951559B2 (en) * 2007-07-25 2011-05-31 E.I. Du Pont De Nemours And Company Recombinant peptide production using a cross-linkable solubility tag
US7829311B2 (en) 2007-07-25 2010-11-09 E.I. Du Pont De Nemours And Company Ketosteroid isomerase inclusion body tag engineered to be acid-resistant by replacing aspartates with glutamate
US7678883B2 (en) * 2007-07-25 2010-03-16 E.I. Du Pont De Nemours And Company Solubility tags for the expression and purification of bioactive peptides
WO2009135212A2 (fr) * 2008-05-02 2009-11-05 Epicentre Technologies Corporation Marquage sélectif d'arn par ligature en 5'
US7794963B2 (en) 2007-11-02 2010-09-14 E.I. Du Pont De Nemours And Company Use of tetracysteine tags in fluorescence-activated cell sorting analysis of prokaryotic cells producing peptides or proteins
US8883146B2 (en) 2007-11-30 2014-11-11 Abbvie Inc. Protein formulations and methods of making same
WO2009073569A2 (fr) 2007-11-30 2009-06-11 Abbott Laboratories Formulations de protéine et leurs procédés de fabrication
US8524244B2 (en) 2008-02-14 2013-09-03 Bristol-Myers Squibb Company Targeted therapeutics based on engineered proteins that bind EGFR
PL2274331T3 (pl) 2008-05-02 2014-04-30 Novartis Ag Ulepszone cząsteczki wiążące oparte na fibronektynie i ich zastosowanie
JP2011520961A (ja) 2008-05-22 2011-07-21 ブリストル−マイヤーズ スクイブ カンパニー 多価フィブロネクチンをベースとする足場ドメインタンパク質
EP2316030B1 (fr) * 2008-07-25 2019-08-21 Wagner, Richard W. Procédés de criblage de protéines
CN102227638B (zh) * 2008-09-30 2015-05-20 Abbvie公司 Rna展示的改良方法
TWI496582B (zh) 2008-11-24 2015-08-21 必治妥美雅史谷比公司 雙重專一性之ｅｇｆｒ／ｉｇｆｉｒ結合分子
US20100158846A1 (en) * 2008-12-18 2010-06-24 E. I. Du Pont De Nemours And Company Hair-binding peptides
US20100158822A1 (en) 2008-12-18 2010-06-24 E .I. Du Pont De Nemours And Company Peptides that bind to silica-coated particles
US20100158837A1 (en) 2008-12-18 2010-06-24 E. I. Du Pont De Nemours And Company Iron oxide-binding peptides
US8287845B2 (en) * 2008-12-18 2012-10-16 E I Du Pont De Nemours And Company Hair-binding peptides
US20100247590A1 (en) * 2009-03-30 2010-09-30 Johnson & Johnson Peptide-Based Systems For Delivery Of Cosmetic Agents
US8481678B2 (en) 2009-03-30 2013-07-09 E I Du Pont De Nemours And Company Peptide-based tooth whitening reagents
JP5733784B2 (ja) * 2009-09-24 2015-06-10 国立大学法人埼玉大学 ｃＤＮＡ／ｍＲＮＡ−タンパク質連結体の効率的合成法
WO2011051327A2 (fr) 2009-10-30 2011-05-05 Novartis Ag Petites protéines à chaîne unique de type anticorps
WO2011051466A1 (fr) 2009-11-02 2011-05-05 Novartis Ag Molécules de liaison anti-idiotypiques à base de fibronectine et leurs utilisations
WO2011092233A1 (fr) 2010-01-29 2011-08-04 Novartis Ag Conjugaison de levures pour produire des combinaisons de liants à base de fibronectine à haute affinité
CA2789125A1 (fr) 2010-02-10 2011-08-18 Novartis Ag Procedes et composes pour la croissance de muscle
CN102939102A (zh) * 2010-04-09 2013-02-20 乌得勒支大学控股有限责任公司 重组多聚流感蛋白
SI2558577T1 (sl) 2010-04-16 2019-05-31 Nuevolution A/S Bifunkcionalni kompleksi in metode za pripravo in uporabo takšnih kompleksov
TW201138808A (en) 2010-05-03 2011-11-16 Bristol Myers Squibb Co Serum albumin binding molecules
EP3091028A1 (fr) 2010-05-26 2016-11-09 Bristol-Myers Squibb Company Protéines d'échafaudage à base de fibronectine ayant une stabilité améliorée
US9512199B2 (en) 2010-07-30 2016-12-06 Novartis Ag Fibronectin cradle molecules and libraries thereof
DE102010056289A1 (de) 2010-12-24 2012-06-28 Geneart Ag Verfahren zur Herstellung von Leseraster-korrekten Fragment-Bibliotheken
US9880160B2 (en) 2011-03-15 2018-01-30 X-Body, Inc. Antibody screening methods
EP3415619B1 (fr) 2011-04-28 2020-12-16 The Board of Trustees of the Leland Stanford Junior University Identification de polynucléotides associés à un échantillon
EP2742153B1 (fr) 2011-08-01 2018-09-05 The General Hospital Corporation Banques de protéines et de peptides
BR112014008804A2 (pt) 2011-10-11 2017-06-13 Medimmune Llc suportes derivados de tn3 específicos para cd40l e métodos de uso dos mesmos
US9416179B2 (en) 2011-12-05 2016-08-16 X-Body, Inc. PDGF receptor beta binding polypeptides
EP2975121A4 (fr) * 2013-03-13 2016-07-20 Univ Tokyo Séquence de liaison d'acide nucléique
AU2014302811B2 (en) 2013-06-28 2020-01-23 X-Body, Inc. Target antigen discovery, phenotypic screens and use thereof for identification of target cell specific target epitopes
CN103382579B (zh) * 2013-07-06 2015-10-21 中国科学院成都生物研究所 一种体外筛选多肽的方法
EP3779440A1 (fr) 2013-09-23 2021-02-17 X-Body, Inc. Procédés et compositions pour la génération d'agents de liaison contre des antigènes de surface cellulaire
WO2015101516A1 (fr) * 2013-12-31 2015-07-09 F. Hoffmann-La Roche Ag Enrichissement d'oligonucleotides de pleine longueur par transcription/purification à médiation par translation
EP3102245B1 (fr) 2014-02-05 2021-09-08 Molecular Templates, Inc. Procédés de criblage, de sélection et d'identification de polypeptides de recombinaison cytotoxiques fondés sur une diminution provisoire de la ribotoxicité
AU2015231170B2 (en) 2014-03-20 2019-10-03 Bristol-Myers Squibb Company Serum albumin-binding fibronectin type III domains
JP6478392B2 (ja) * 2014-12-26 2019-03-06 国立研究開発法人産業技術総合研究所 核酸リンカー
CA2977675A1 (fr) 2015-03-12 2016-09-15 Medimmune, Llc Procede de purification de proteines de fusion d'albumine
EP3353199B1 (fr) 2015-09-23 2020-02-19 Bristol-Myers Squibb Company Domaines de la fibronectine de type iii se liant à l'albumine sérique à vitesse de dissociation élevée
KR20230047506A (ko) 2016-05-02 2023-04-07 엔코디아, 인코포레이티드 암호화 핵산을 사용한 거대분자 분석
EP3472355A4 (fr) 2016-06-15 2020-07-29 Genecapture, Inc. Compositions, procédés et dispositifs comprenant des molécules-capteurs à boucle-tige
MA45491A (fr) 2016-06-27 2019-05-01 Juno Therapeutics Inc Épitopes à restriction cmh-e, molécules de liaison et procédés et utilisations associés
CA3028002A1 (fr) 2016-06-27 2018-01-04 Juno Therapeutics, Inc. Procede d'identification d'epitopes peptidiques, molecules qui se lient a de tels epitopes et utilisations associees
AU2018238892B2 (en) 2017-03-21 2020-07-23 Fujifilm Corporation Peptide compound and method for producing same, composition for screening use, and method for selecting peptide compound
KR102556494B1 (ko) * 2017-10-31 2023-07-18 엔코디아, 인코포레이티드 핵산 암호화 및/또는 표지를 이용한 분석용 키트
IL297543A (en) 2017-11-30 2022-12-01 Arrakis Therapeutics Inc Nucleic acid-binding photoprobes and their uses
WO2019148293A1 (fr) 2018-02-02 2019-08-08 Interface Biologics, Inc. Formulations de verre comprenant des dimères stéroïdiens et utilisations associées
TWI830718B (zh) * 2018-02-09 2024-02-01 日商住友化學股份有限公司 核酸分子之製造方法
EP3778914A4 (fr) * 2018-03-30 2022-01-19 Sumitomo Chemical Company, Ltd. Procédé de production d'arn simple brin
WO2019236644A1 (fr) * 2018-06-05 2019-12-12 Arrakis Therapeutics, Inc. Bibliothèques codées et procédés d'utilisation pour le criblage de cibles d'acide nucléique
CN115956083A (zh) 2020-05-01 2023-04-11 波纹疗法公司 异二聚体组合物及用于治疗眼部病症的方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5391723A (en) * 1989-05-31 1995-02-21 Neorx Corporation Oligonucleotide conjugates
US5843701A (en) * 1990-08-02 1998-12-01 Nexstar Pharmaceticals, Inc. Systematic polypeptide evolution by reverse translation
AU8124694A (en) * 1993-10-29 1995-05-22 Affymax Technologies N.V. In vitro peptide and antibody display libraries
DE19646372C1 (de) * 1995-11-11 1997-06-19 Evotec Biosystems Gmbh Genotyp und Phänotyp koppelnde Verbindung
DK0862656T3 (da) * 1995-11-21 2001-04-09 Univ Yale Unimolekylær segmentamplifikation og -detektering
US6117635A (en) * 1996-07-16 2000-09-12 Intergen Company Nucleic acid amplification oligonucleotides with molecular energy transfer labels and methods based thereon
US5842701A (en) * 1996-10-08 1998-12-01 Smith International, Inc. Dual functioning seal for rock bits
CA2268353A1 (fr) 1996-10-10 1998-04-16 Henrik Garoff Vecteurs alphavirus et retrovirus
DE69730157T2 (de) * 1996-10-17 2005-07-28 Mitsubishi Chemical Corp. Molekül, welches genotyp und phänotyp zusammenführt und dessen anwendungen
ATE332368T1 (de) * 1997-01-21 2006-07-15 Gen Hospital Corp Selektion von proteinen mittels rns-protein fusionen
US6261804B1 (en) * 1997-01-21 2001-07-17 The General Hospital Corporation Selection of proteins using RNA-protein fusions
US5935791A (en) * 1997-09-23 1999-08-10 Becton, Dickinson And Company Detection of nucleic acids by fluorescence quenching
DE69800415T2 (de) * 1997-12-22 2001-07-19 Genset Paris Prostatakrebs-gen
US5985575A (en) * 1998-05-20 1999-11-16 Wisconsin Alumni Research Foundation Tethered function assay for protein function
PT1870417E (pt) * 1999-07-27 2012-06-01 Bristol Myers Squibb Co Métodos de ligação de aceitador peptídico
JP4803933B2 (ja) * 1999-08-27 2011-10-26 ブリストル−マイヤーズ スクウィブ カンパニー インビトロ翻訳タンパク質の符号化方法および選別方法

Also Published As

Publication number Publication date
DE60034566D1 (de) 2007-06-06
AU781783B2 (en) 2005-06-16
ES2284508T3 (es) 2007-11-16
CA2377468A1 (fr) 2001-02-01
PT1196637E (pt) 2007-07-04
US7790421B2 (en) 2010-09-07
HK1045334A1 (zh) 2002-11-22
NO20020348L (no) 2002-01-23
EP1196637A4 (fr) 2003-11-12
PT1870417E (pt) 2012-06-01
NO20020348D0 (no) 2002-01-23
US20060246549A1 (en) 2006-11-02
CA2693274C (fr) 2013-05-28
ES2383332T3 (es) 2012-06-20
EP1870417B1 (fr) 2012-03-28
EP1870417A2 (fr) 2007-12-26
JP2010284172A (ja) 2010-12-24
AU6111200A (en) 2001-02-13
KR20020033743A (ko) 2002-05-07
EP1196637A1 (fr) 2002-04-17
US20020182687A1 (en) 2002-12-05
WO2001007657A1 (fr) 2001-02-01
HK1112007A1 (en) 2008-08-22
EP1196637B1 (fr) 2007-04-25
ATE360706T1 (de) 2007-05-15
US7078197B2 (en) 2006-07-18
JP5512463B2 (ja) 2014-06-04
DE60034566T2 (de) 2008-01-03
JP2003505094A (ja) 2003-02-12
JP4766808B2 (ja) 2011-09-07
AU2005211548B2 (en) 2007-11-29
ATE551352T1 (de) 2012-04-15
EP1870417B9 (fr) 2012-08-01
DK1870417T3 (da) 2012-07-16
EP1870417A3 (fr) 2008-06-11
DK1196637T3 (da) 2007-07-30
AU2005211548A1 (en) 2005-10-13
CA2377468C (fr) 2010-04-20
CA2693274A1 (fr) 2001-02-01
CY1113185T1 (el) 2016-04-13
US6429300B1 (en) 2002-08-06

Similar Documents

Publication Publication Date Title
HK1112007A1 (en) Peptide acceptor ligation methods
WO1999057325A3 (fr) Melanges d'enzymes
BG107861A (en) Isothermal amplification of nucleic acids on a solid support
WO1999064047A8 (fr) Composes antiviraux
HK1086296A1 (en) Process for producing dipeptide
HK1047697A1 (en) Immunostimulatory nucleic acids.
WO2003012119A3 (fr) Procede d'amplification de l'acide nucleique
AU4332399A (en) Rna polymerase chain reaction
AU1951495A (en) Alphavirus rna as carrier for vaccines
WO1995006764A3 (fr) Oligonucleotides ayant une activite de segmentation de l'arn
ZA99873B (en) Novel dihydroxyhexanoic acid derivatives.
ZA98387B (en) Novel microorganisms.
WO2001000577A3 (fr) Preparation de piperidine-4-ones substituees
AU1908100A (en) Isothermal nucleic acid amplification methods
IT1301737B1 (it) Premitallone per pneumatici.
AU2001252390A1 (en) Nucleic acid immunization
PT1064265E (pt) Sintese de 3-amino-2-cloro-4-metilpiridina a partir de malononitrilo e acetona
AU2001295580A1 (en) Nucleotide sequences which code for the dep67 protein
IL142680A0 (en) Minimal promoters and uses thereof
AU2001272533A1 (en) Nucleotide sequence which codes for the alr gene
GB9914600D0 (en) Novel,process
AU4692501A (en) Laminaribiose phosphorylase, process for producing the same and process for producing laminarioligosaccharide by using the enzyme
HK1031881A1 (en) Process for preparing 8-cyclopentyl-6-ethyl-3-Äsu bstitutedÜ-5,8-dihydro-4H-1,2,3A, 7,8-pentaaza-as-indacenes and intermediates useful therein.
AU2001234795A1 (en) Process for obtaining 1, 2, 3, 5, 6, 7, 8, 8a-oltahydro-1, 2, 8, 8tetramethylnaphthalen-2-yl!etan-1-one
AU2001269068A1 (en) Disubstituted 7,9-guaninium halides as telomerase inhibitors